|
Basic InformationMore InformationLatest NewsPreventive Surgeries May Be Lifesaver for Women at High Cancer RiskFood Better Than Supplements for Cancer Prevention: ExpertIn Early Trial, Targeted Therapy Fights Advanced MelanomaRectal Cancer on the Increase in Younger PeopleNicotine Can Fuel Breast Cancer, Study SuggestsVitamin D May Influence Genes for Cancer, Autoimmune DiseaseAlcohol May Raise Risk for Certain Breast CancersInner Workings of Gene Tied to Breast, Ovarian Cancer RevealedVirtual Colonoscopy Can Spot Cancers Outside ColonPalliative Care May Boost Mood, SurvivalCancer Care Differs by Race, Language, and Health StatusNovel Ovarian Cancer Test Shows PromisePatient Role in Cancer Treatment Decisions VariesEstrogen Alone Does Not Increase Lung Cancer RiskMass Spectrometer Test IDs Cancer With High AccuracyDocs Shying Away From Drug That May Prevent Prostate CancerLess May Be More When Treating Early Hodgkin'sRecession Causing Cancer Patients to Quit Life-Extending DrugsGene Variants, High BMI Linked to Prostate Cancer MortalityA New Marker to Spot Aggressive Breast Cancers?Hormone Combination Effective in Metastatic Breast CancerHealth Tip: Screening Early for Colorectal CancerBladder Cancer Linked to Compounds in Processed MeatVaccine Shows Some Promise Against Advanced CancersBreast Cancer's DNA Yields More SecretsVaccine Boosts Survival for Men With Advanced Prostate Cancer: StudyGenetics-Based Risk Score Tied to Risk for Breast CancerMany With Low-Risk Prostate Cancer Get Aggressive TherapyChildhood Cancer May Be Linked to Later Heart ProblemsMultiple Genetic Variants Add to Prostate Cancer RiskFDA Panel Advises Against Bevacizumab for Breast CancerAvastin Largely Safe for Patients With Type of Advanced Lung CancerStudy Suggests Painters Face Increased Risk of Bladder CancerSix-Gene Signature May Predict Pancreatic Cancer PrognosisCigarette Smoke May Up Cancer Risk By Interfering With GenesStudy Suggests Higher Cancer Rate Among IVF BabiesNew Clues to How Cancer Patients' Genes Influence TreatmentTelecare Management Lowers Pain, Depression in CancerExperts Issue New Guidelines on Breast Cancer DrugsPersonal, Substantial Diagnosis Talk Preferred by PatientsStudy Suggests Link Between HPV, Skin CancerFish Oil Usage Linked to Lower Risk of Certain Breast CancersU.S. Cancer Death Rate Keeps Falling: ReportMany Docs Deliver Cancer Diagnosis Badly: StudyCould Hot Weather Affect Results of a Colorectal Cancer Test?CDC: U.S. Colorectal Cancer Screening Rates UpShorter Telomere Length Again Linked to CancerBreast Cancer Gene May Raise Men's Risk, TooBlack Cancer Patients Twice as Likely to Die From DiseasePSA Test Does Cut Prostate Cancer Deaths, Study Finds LinksBook Reviews |
| |
'Watchful Waiting' Often Best Strategy for Slow-Moving Prostate Cancer
by -- Robert Preidt
Updated: Jun 18th 2010
FRIDAY, June 18 (HealthDay News) -- For patients with prostate cancer that has a low risk of progression, active surveillance, also known as "watchful waiting," may be a suitable treatment option, according to a large-scale study from Sweden.
The issue of how (or whether) to treat localized prostate cancer is controversial because, especially for older men, the tumor may not progress far enough to cause real trouble during their remaining expected lifespan. In those cases, deferring treatment until there are signs of disease progression may be the better option.
The researchers looked at almost 6,900 patients from the National Prostate Cancer Registry Sweden, age 70 or younger, who had localized prostate cancer and a low or intermediate risk that the cancer would progress. From 1997 through December 2002, over 2,000 patients were assigned to active surveillance, close to 3,400 underwent radical prostatectomy (removal of the prostate and some surrounding tissue), and more than 1,400 received radiation therapy.
After a median follow-up of just over 8 years, the surveillance group had a much higher death rate from causes other than prostate cancer -- 19.2 percent, compared with 6.8 percent in the prostatectomy group and 10.9 percent in the radiation therapy group.
This suggests that patients with a shorter life expectancy were more often selected for active surveillance rather than surgery or radiation therapy, the researchers said.
The patients who underwent surgery for prostate cancer had a lower risk of dying from prostate cancer than those in the active surveillance group. However, the difference in absolute risk of patients dying from prostate cancer was very small -- only 1.2 percent after 10 years of follow-up.
The researchers concluded that, based on these findings, active surveillance is the best strategy for many patients with low-risk prostate cancer.
"With a 10-year prostate cancer-specific mortality of less than three percent for patients with low-risk prostate cancer on surveillance, this strategy appears to be suitable for many of these men," wrote Dr. Par Stattin, of Umea University, and colleagues.
The study was published online June 18 in the Journal of the National Cancer Institute.
More information
The U.S. Agency for Healthcare Research and Quality has more about treatment of localized prostate cancer.
This article: Copyright © 2010 HealthDay. All rights reserved. |
